Buyers. Live from the world headquarters in New York, I'm Vonnie Quinn.
The rally underway. The Nasdaq may be lower, but it seems like almost everything else is higher. The Nasdaq 100 up 3.3%.
The S&P up 2.5%. Gold is bouncing back, front-end yields higher. We will see if we get any glimpses into appetites, but really stocks are the story today. Everything is higher, and there could be something nasty brewing.
AMD, nothing to do with the terminal at Nvidia. Oppenheimer higher, upgrading AIM due to the equivalent of buy. The HVAC supplier benefiting from the data center buildout.
Sable Offshore is one of the biggest losers in the Russell, saying it will struggle to repay near-term debt because its only customer halted purchases. They did not identify who the purchaser is, but we believe, based on sales we saw earlier this year, it's being sent to a Chevron refinery, and that may be the customer in question.
Nvidia down about 5%. The amount of money moving through that stock is somewhere in the neighborhood of $64.5 billion, about five times the amount of money moving through the second-most actively traded company stock. Take a listen to what Jensen Huang, the CEO of Nvidia, told Bloomberg on October 14 for an upcoming episode of "The Circuit."
We don't take our position for granted. We came from nothing, and we have to earn our keep every day. We have competitors in every industry, in every country. With respect to the size of the market, just remember it's just a number. Nvidia can only be as large as the pond we are in, the market we are in.
Today, but Nvidia's own investors, not so much. Will Jensen Huang survive?
That's a question everybody wants the answer to. I think we are only at the beginning of the process of finding out whether that will be the case or not. His board has said they will investigate reports that he may have been the subject of foreign espionage efforts. They will look into that and see what details emerge. Those will be the details that determine whether he stays in his position.
All this raises the issue of risk. Jensen Huang has no succession plan in place, and he has 16 direct reports to rapidly implement his decisions. How unusual is that in the tech world, where the founder and CEO has much more sway than in other industries?
It is by design. It's absolutely deliberate that he has done this. He says this is the only way to make a company that he believes can respond to the rapidly changing nature of the tech industry. Other companies have important leaders, but in terms of structure, everything goes through him.
He will be before a congressional committee next week. Does the board have to wait for congressional findings in order to come back with its own findings, or are they two separate things here?
They are separate things. He's been the subject repeatedly of congressional attempts to have him appear and testify, but there's no ability to compel him to do so. That will probably only change after January. At the moment, it's just posturing that doesn't have a lot of teeth, and that will change. But we would expect the board investigation will come to a conclusion ahead of any political process.
Thank you so much for all that context.
All the AI trade we saw last week, a big week. We met massive selections in there, so much uncertainty regarding the Fed and everything else. What questions are you getting most these days from your investors and clients?
We've had an unbelievable last five business days. What we saw last week was, frankly, the market trying to predict and react to policy changes. We can't predict what policy will look like. We do know that the economic impact of policy decisions happens a year or two following that. As we cut through the noise, there are big things we think are constant regardless. The first is around deficits. Regardless of which party is in power, there are record deficits today. We have fiscal spending that is really high. We need to rein that in, and we don't see that happening. That does not bode well for government debt, longer-term government debt. We are not excited by it. Position-wise, we also look at gold as a balancing portfolio. That is one thing that doesn't change regardless of the headlines.
The second aspect is AI. I say that as a blanket term. We are not putting the genie back in the bottle there. With regard to AI, you can't have AI without data centers, and data center legislation is statewide, it is not federal. So if you have a state or government official that's more restrictive in one state, you will go to another state. What is constant through it is the materials required to be able to build it. Whether it's copper, aluminum, those types of things are stable, and that's a big backdrop. Then, of course, we have earnings, which are looking pretty good.
I want to talk more about the AI story. Now that there has been pushback on the construction of data centers, it seems it's good news for hyperscalers. Then you have this Nvidia issue. We know Nvidia is a big underwriter of the whole ecosystem. Will some of those companies that Nvidia had been funding need to tap the debt market?
Hyperscaler debt issuance has been a topic and, frankly, a focus we've been seeing this year. These are companies that barely had any debt. We're seeing a record amount of debt from these companies to be able to fund the AI buildout. Looking at the capital stack and leverage ratios, they're still really low. Nvidia is one of those companies in the broader ecosystem, so that is one thing to look at. To your point, there are between 3,000 and 5,000 data centers today operating in the U.S. That same amount is in different phases of planning. So yes, our job is to be able to look through the noise, and right now the signal is strong.
You talked about balancing portfolio. Is there one piece of advice you can give to someone who is concerned there is fragility in the market, enough to make someone want to insulate their portfolio?
We would say we are 80% through S&P earnings. We are seeing about 30% year-over-year earnings growth. So I can understand the concern about maybe the concentration of it, but we are in the early innings. Arguably, we have not seen the productivity gains of AI through the broader ecosystem. We haven't seen a real benefit just yet. So while there is that angst, our goal with our investing portfolio is for durable earnings growth, and we see that still in the space.
You look at the Fed and other central banks, they are all in tightening mode. What does it mean for margins, which have only been doing well, and a lot of people question whether we've reached peak margins?
Margins right now are good. The Fed did not hike in the last meeting. We do expect them to hike because we haven't seen price stability just yet. Inflation is higher. But as we are looking at margins and earnings growth, we are still seeing earnings expansion across the board. So the rate hiking cycle is particular to some subset of companies that rely on the debt market and financing. We think underweight small-cap companies are of preference. In areas whereby there's a greater reliance on rates, financing and leverage, there is a challenge, which is why we are a little apprehensive on some of those sectors.
We hope to have you back after some sleep, because I'm not sure we will get any for the next few weeks. That's the head of portfolio construction and analytics at Citi Wealth. Coming up, the former Fed governor joins us live with what the central bank can do next.
And from the FOMC to the pharmas, CVS is set to spin off its retail business. CVS CEO David Joyner joins us to talk about the implications.
And the first report of a new company and a look at life ahead for the media at large. All of that and more, coming up. This is "The Close" on Bloomberg.
We've got to come to terms with this cost side and inflation side failure.
That was Austan Goolsbee on the difficulties of bringing inflation down to the Fed's 2% target. His comments ahead of tomorrow's CPI report, which is expected to show a slowdown in price increases versus September's sprint. Joining us is a former Fed governor and chair of Wells Fargo. Given the fact that the Federal Reserve held off on raising rates in October before the midterm election, and the fact that policymakers themselves expect to raise rates one more time before the end of the year, does it matter what tomorrow's report shows?
I don't think it matters a whole lot. It's hard to imagine a report that is going to change the trajectory of where they are headed. I think as importantly, every indicator of the labor market and the strength of the economy has said there's no weakness the Fed has to protect against in raising rates, and there's no evidence that rates are restrictive right now.
You point out the Fed is the only government entity charged with the responsibility for inflation control. Yet we know that a whole slew of Democrats were elected earlier this month to address and solve for inflation. As a former monetary policymaker, how do you think about what elected lawmakers can do to try to temper inflation?
There's quite a bit that they can do, because fiscal policy and supply-side economics have driven most of the inflation. But at the same time, the Fed is the only entity of government that is charged with controlling inflation. And even though the Fed is not political in terms of partisan politics, Democrats versus Republicans, you can't help but hear the anger in the public's mind about how long inflation has gone on and how high it's gotten. And I just think it's irresponsible if the Fed doesn't take any action.
If there is an AI slowdown, is that better or worse in your term for the labor market?
I'm not sure right now it will make a whole lot of difference if you are talking about data centers in terms of the labor market.
The Fed is counting on this AI productivity boom to continue to stay on its current path. If it were to slow down, would that make the Fed reconfigure a little bit its policy path?
Honestly, I don't think you've seen the productivity boom start yet. I think it is largely absent. You are seeing some signs that it might be picking up, but it's certainly not anything like what is anticipated to happen as AI gets more and more embedded in all companies' operations.
Now that we've seen the Democrats sweep Congress and control the House and Senate, a lot of people are saying this means President Trump will have less sway over the Federal Reserve, that he can't do as much to influence Fed policymakers. Certainly his efforts to remove Lisa Cook may be pushed back a little bit. What do you anticipate from President Trump over the next two years, as he continues and closes out his lame-duck presidency, when it comes to his vendetta against the Federal Reserve and certain members of the Fed?
It's really hard to know. Once you see a new Congress, primarily a Democratic Congress, and the Senate is certainly not likely to reward an attack on the independence of the Fed with confirmation of a Fed nominee. So I think Trump's ability to replace someone on the Fed after he has removed them is going to be stifled. Whether that changes his intent to show that he has the authority and to confirm that he has the authority to remove members of the Federal Reserve Board is something that remains to be seen. I think there's a scheduled meeting with Lisa Cook in December, and it will be really interesting to see where that goes.
We will have an auction of 10-year notes tomorrow, but the front end has bounced around. We're at 4.54 on the two-year yield. What is the market saying?
I'm honestly not sure I know as far as what it's saying about potential Fed action. Expectations are the Fed will move, and I think it will be a great disappointment if the Fed does not do anything. It seems to me it's really hard to continue to say that you don't believe that policy is restrictive and you don't believe inflation is too high, and you have one tool to deal with it and you're not going to use that tool.
The fact that Brent crude has come down to $92, does that give the Fed a little more leeway?
That's one reading, one price level. You would expect that, and I think the Fed anticipates that ultimately gas prices will come down and diesel prices will come down, but it's going to take a while for that to move through the rest of the economy. It's the other parts of the economy more than necessarily the commodities-driven groceries or gasoline prices right now that they are concerned about.
Thanks so much for joining us, Betsy Duke, former chair of Wells Fargo. Coming up, the first earnings reports and a look at the Paramount-Warner megadeal. This is "The Close" on Bloomberg.
Tom Bortok calls, look at some of the big movers on the back of analyst recognition. AMD being upgraded to market perform after another bullish earnings call. The price target set at $600 as it did tick AI access a tailwind to GPU and CPU. That stock higher by a slight amount. Eli Lilly, a new high of $1,700 a share from keeping its buy rating, shares up almost 5%. Finally, Fox upgrading on the back of the Roku acquisition. Shares up 2% there. Those are some of our top analyst calls.
Most stocks are higher today. We're also watching Skydance, the media giant due for its first earnings report after the merger. Joining us live is the managing director at Citigroup. One of the questions being put to management is how they will manage the debt pile now that interest rates have gone up. What do you expect to hear?
I think about it mostly as a cost-cutting story. The numbers in 2026, the company will do about $12.5 billion of EBITDA. The guidance is about $20 billion of EBITDA, 18.5 billion. To me, this is less about a top-line story right now and more about, can they realize the cost synergies and how quickly.
I'm curious what you think of Microsoft winding down a deal with Oracle on cloud capacity. There are concerns about Oracle's debt levels and costs against default have been rising. What does it mean for Skydance, given that Larry Ellison has put his financial heft behind the high-net acquisition?
I think there's one controversy for Skydance, which is the company is probably going to do about $3 billion of cash flow the first year. The dividend payment, if they keep it, which is a nickel a share, will probably run about a billion dollars. That's a very large percentage of your cash flow to pay out in the form of a dividend. Obviously, most of that goes to the Ellison family since they control a lot of the shares. But there's a question about whether they should sustain the dividend at prevailing levels or not, reduce that even and focus more on rapid debt reduction. The implication is that they would have less liquidity.
More than half the profits come from linear TV. We are about that today, and what kind of streaming pricing power the company now has.
Linear TV is really interesting. One sleeper issue for 2027, and I can name the number of clients on one hand that are talking about this. It's a very much minority position. But the rate of cutting is coming down. It dropped to 3 million in 2024 and 2025. I think there's a pretty good chance that cord cutting can continue to moderate. The reason for that is about half of American households care about sports and the other half don't. If you don't care about sports, you've probably already cut the cord. So we are gliding to a more durable cord. My sleeper issue is the cord cutting lottery, and a lot of the headwinds baked into the Skydance equity begins to moderate.
What is the number one thing Skydance can and should do, given that Netflix seems to be struggling to show growth right now?
My north star, and people used to laugh at me about this, but when I look at the trends of what consumers are watching, it's all user-generated content. It's all YouTube. So I want to see these traditional companies lean into user-generated content. It's happening because of AI, and AI is only going to get bigger.
Thank you for joining us, Jason. We will get the Skydance results after the market closes. David Joyner joins us to discuss his upcoming retail spinoff. This is "The Close" on Bloomberg.
Let's take a look at shares of CVS Health, up 5.3%. Company executives defended the impending spinoff of the retail pharmacy business at a health care conference earlier. CEO David Joyner saying the company made the decision from a position of strength, and he joins us now live with more. Welcome to Bloomberg. You look at CVS today, and it includes an insurer, pharmacy benefits manager, pharmacies and clinics. The point of this vertical integration was to make health care yours. What do you think went wrong? What didn't go according to plan?
What I've been able to do over the past four quarters is get our business in a position of health and strength, as we mentioned in the opening. Eight quarters above the beat and a raise on our guidance. A lot of the focus was on building the strength of Aetna and the Medicare business, but equally as important is building the retail business, which up until this point was guiding down -5%. Now you look at where we have been, this will be our third consecutive year of growth in the retail pharmacy business. I look at the combination of businesses, and I would not look at anything in terms of failing. It is saying the marketplace changed. We got a chance to assess from a position of strength, meaning the businesses were running and operating well. We afforded this set of decisions that was actually going to be able to unlock the next set of value for the businesses. As we look at the retail business, which is where the business will be standing alone, they are now spinning from a position of strength to capitalize on all the investments we have made, particularly in that business.
Do you have any interest in those pharmacies? Has anyone come forward and said we would like to buy some of these?
At this point, no. Part of what we've looked at in the transaction is looking where the businesses we believe work better together than alone. If I look at the CVS Health organization, it still retains the Aetna asset with the big Medicare franchise. Two businesses leaning into the value-based care models, which is about trying to change the payment models to focus on improving the cost and the health outcomes for the patients. When I look specifically at the retail business, we believe this business will stand on its own. We have not been approached, nor do I expect for that to be approached for that asset, because we are building a case that this will be a standalone company that will be able to serve customers better. It will be more focused. Important to that business.
You do have about $60 billion of debt on the balance sheet. How much will that end up on the retail portion's shoulders, and how confident are you that you can get investment grades in both companies?
That's a great question, and one we thought a lot about because we wanted to make sure both of these businesses were able to operate with a strong balance sheet. We expect solid investment grade positions on both of the companies, and we expect the debt levels and the ability to have a strong balance sheet to invest in the growth will be important. This is not about spinning a weaker company. This is about introducing one great company that is now splitting into two great companies.
How will you divide that debt?
There will be a portion of the debt that is allocated to our retail business. Again, with the mindset this will be solid investment grade. We will not be levering up the retail business. This is what we believe will be two companies with a strong balance sheet and investment-grade capabilities to make sure there's enough capital for both businesses.
You have a profitable specialty pharmacy that will be kept at CVS Health, while others are going to CVS Pharmacy. Why are you separating them that way? Some critics could argue you are carving off the less profitable retail assets to boost profits at the remaining company. How would you respond to that?
I look at pharmacy in two different ways. There is the specialty pharmacy and CVS Pharmacy. CVS Pharmacy serves the non-specialty customer very well. That is 90% of the customers that access pharmaceuticals. The last 10% that is on these high-cost specialty medications require a different set of capabilities to serve those members. You have to understand they are prescribers. Ultimately, the payers are most concerned about that category because that is the fastest-growing part of pharmacy today. There is an expectation that the PBM will create the appropriate competition to lower the cost for the payer and make sure you have the specialization to serve this important, rare and chronic patient population.
Two of the largest retail pharmacy chains have failed in recent years. Rite Aid went bankrupt, and Walgreens went private at a fraction of its historical value. Why do you think CVS Pharmacy will succeed as a standalone public pharmacy company when two close competitors failed?
Two very different examples of the decisions and the path that these organizations took. At a time when there was reimbursement pressure in the marketplace, we were choosing to invest. It is a tough decision in terms of do you invest in the retail business? As I mentioned earlier, we were demonstrating we were actually declining -5%, but we stated this was a durable, viable market. We believe it will continue to grow. We have an aging population that needs a medication. They need convenient access and the experience to deliver to the homes. We did three things. We invested heavily in our colleagues, along with technology, to make the consumer experience better and make our colleague experience better to serve those members. We also invested heavily in the reimbursement model. We went to a cost-based model that allowed us to get rid of what we call cross-subsidization. There was a model that did not work well, so we, as a PBM as well as a pharmacy, led the effort to try to rationalize the pricing model, which leaves us with a cost-based position that we can serve all of our members profitably and then allow our payer partners, the other PBMs, to participate in the economics. Being the largest purchaser of a pharmacy, the largest purchaser of pharmaceuticals in the country. And we believe that cost position, being a low-cost provider with the highest service model to be able to serve our patients and consumers, sets us up for success regardless of what happens in the marketplace going forward.
This move, do you think it nullifies the likes of Elizabeth Warren and Josh Hawley, who had been looking at breaking up conglomerates or calling for it? Did you get in ahead of continued calls?
I don't know that any decision or any move we make nullifies a lot of the headlines of the day, other than we are doing what we believe is right for our customers. That includes the patients we serve and the payers that are expecting us to manage the underlying cost and quality of health care in the country.
What is your next plan? You have been in this job two years and already executed several pretty big plans. What is next?
The plan right now, and what is in front of my entire management team, is to execute as we have the last two years. My expectation to the team is we don't lose focus. There is obviously a lot of work to be done between now and the time that we would spin CVS Pharmacy. Continue to deliver. My CFO Brian Newman and I have a saying, which is the say-do ratio. This is what we say we are going to do and then deliver, and what we did the last eight quarters is what we expect to do the next six as we continue to operate and run the business.
You took over CVS when it was in crisis a few years ago. How long do you plan to stick with the company?
I am 40 years with the company. Combined, I feel like I am a lifer. I love this company, I love what we do. Could not be more proud of the value we deliver for our customers and the consumers. My job is to continue to lead the path as we create the next chapter in this company.
It seems to be pretty successful so far. Look forward to having you back. That's CVS CEO and Chairman David Joyner. Staying on the topic of dealmaking, Morgan Stanley boosting its stature in the IPO world, buying fintech company Vinyl Equity in a move to... Joining us. What exactly does this company do for clients?
Thank you for having me. It is an exciting day for Vinyl, it is an exciting day for Morgan Stanley, and most importantly, it is an exciting day for our workplace clients who have been asking us for this functionality for a number of years. As many are aware, the transfer agent plays a very important role in equity capital markets because under federal securities law, it is the source of truth for stock ownership. It is the official ledger in terms of who owns what. And historically, a couple of legacy firms have dominated the space, doing the same thing in the same way for a very long time. Vinyl is a new entrant in the industry, but they are technology-first, cloud-based, and they have solved a number of the historical pain points that our clients have been asking for. The combination of the Vinyl technology with the broader Morgan Stanley workplace business enables us to address client challenges in a way that will be very difficult for our competitors to replicate.
Talk about the growing importance of the workplace business, how it has become a bigger part of wealth management overall. How do you see that evolving over the next two years, five years?
Sure. It is important to realize that 90% of wealth in this country is created in the workplace, and our core strategy was about getting in early. When it is just a couple of folks in a garage, you need a management solution. We can deliver that. When the firm gets bigger and you need liquidity, we can facilitate the tender offers. We are the market leader in that. The investment bank to take you public. Then, you convert the private shares to public equity, and we administer the employee stock plan. We grow from a wealth management perspective with the individual employees up to and through retirement. Just to put some round numbers on it, it represents about $1.7 trillion of our $8.4 trillion in assets. And relationships that start in the workplace and end up with financial advisors are now north of $100 billion a year.
How had you been doing it before, and is it more efficient now? Is that what you are saying?
The benefit of having a transfer agent in the mix, from the conversion from private to public, is companies no longer have to send their data outside to third parties. When you are a cap table management client on the private side and then you go public, typically today a lot of sensitive information has to be sent out of the firm. Coordination has to happen with third parties. It is expensive and there is risk. By having the transfer agent within the four walls of Morgan Stanley, we can meet the entire lifecycle of our corporate client needs and become a more compelling partner with them over time. You are exactly right. It is easier, more efficient and less risk for issuers.
This purchase of Vinyl Equity marks the second acquisition in the wealth management space after E*TRADE last year. It is also Ted Pick's second acquisition overall since becoming CEO. How do these two additions round out the wealth management offerings?
On the first case, in terms of E*TRADE, that was expanding the ability for us to deliver unique access to our clients, whether they are advised clients or E*TRADE clients. As we know, the vast majority of companies now are staying private longer, and more wealth is created in the private market space. We have a view that democratizing that, getting more access to the folks, will only help our clients achieve their goals more effectively. The transfer agent, which we announced today, helps us build relationships with those issuers in the first place. Now when we are the capital markets partner to issuers as they go through that journey and they want to source liquidity for their employees, for the early investors, they can do that through the wealth management channel. They can do that through E*TRADE. They can do that through E*TRADE, and they never have to leave the ecosystem. They get better execution, less risk and a partner that can work with them the entire lifecycle.
Just on the broader market --
You are pulling a lot of money this year, something like $500 billion in net new assets alone in the first nine months. What is the biggest concern for these new assets? How to deploy them in an era where the AI trade seems more fragile than ever, or what is the biggest concern?
Obviously, volatility is something that folks are looking at, but for us, when you are in the advice business, more volatility means a bull market for advice. And clients tend to want to do everything right away, and the benefit of working with a financial advisor is that we can leg into different positions what makes the most sense for them to achieve their long-term financial goals. At the end of the day, we are not trading for a specific market price. We are trying to achieve -- for the vast majority of our clients, they are trying to solve for multigenerational legacy issues to make sure that they have the money they need to support their families and their communities. So balancing people's interest in making short-term market decisions versus the benefits of a long-term plan is a job that our financial advisors get up every day to do, and it's something they are excelling at, as you pointed out, as you look at what they brought in through three quarters of this year.
We appreciate you joining us. On the heels of Morgan Stanley buying the fintech and expansion, the driver for the profits at Morgan Stanley.
What a year for the wealth management business. When you see markets like this with the Nasdaq 100 up 3.7%, it's not hard to see where the newfound wealth is coming from.
As much confusion as there has been about the election, what it means for policy and the economy, individual investors have been relentless.
We will talk to Kim Forrest next with Bokeh Capital Partners.
I did my best to inform the policymakers in the United States of the importance of engaging with the Chinese market and making sure that we serve that market for as long as we can. I think we made a mistake, and this mistake is hard to unwind, but I did my best. That's all I can do. There are more Chinese AI researchers than any other nation in the world, and many of them working at the labs. I've been very clear that even though we compete against China, they are not our enemies.
That was Jensen Huang, CEO of Nvidia, back on October 14, speaking with Bloomberg's Emily Chang for an upcoming episode of "The Circuit." Some of those ring a little differently, and we will have to see how the story continues, but certainly we are learning a lot more about the whole affair than even a few days ago when the supplier...
It comes right before Nvidia reports earnings next Tuesday, and there will be a closed-door congressional hearing the following day.
Jensen Huang is no longer on the Anthropic CEO discussion list that was due to happen next week, so there are definitely ramifications already. The market seemed to be shrugging off the Nvidia move. The S&P 500 higher, 2.5% gain for that index. The Nasdaq 100 up 3.7%. Just a handful of companies are lower, and from the neo-clouds and hyperscalers, they are all surging today. Yields, the front end up about four basis points, flattening the curve a little bit. Oil having an effect on the market, continuing to come down with the prospects of a return to any kind of kinetic war with Iran receding even further.
I tried to look for some decliners when it came to individual stocks, and you have Nvidia lower by 4.4%. The gainers, I wanted to highlight Ferguson Enterprises. The story here is that it is benefiting from the data center buildout that's helping to offset weakness in the construction of new residential housing. Within the Philadelphia Semiconductor Index, you have 29 out of 30 names gaining, that group now up 6.9%. Of course, the exception is Nvidia.
Everything else seems to be higher, but Nvidia is the one stock that is lower. Investors really voting with their feet today. This move later today, does it have the potential for broad market ramifications?
Sure, anything related to AI seems to go through wild swings. It seems like a long time ago today, but Friday was a really bad day for AI, and Nvidia could not escape there. And I think for good reasons, it's a bifurcated kind of response. You are either all in or all out. A lot has been changing, and throughout 2026, there has been a lot of questions about the real demand for AI, the profitability of the labs, and anybody using AI, are they getting returns? And what's going to happen with buildout? So we have all these questions, and not a lot of answers.